URBANYL Side Effects

6535715-2 | Thrombocytopenia
on Jan 08, 2010 Female patient from FRANCE , 74 years of age, was treated with Urbanyl (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Urbanyl dosage: . During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), DEPAKINE CHRONO (View Depakine Chrono Review and Depakine Chrono Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TIAPRIDE ^PANPHARMA^ (View Tiapride ^panpharma^ Review and Tiapride ^panpharma^ Label ), AKINETON (View Akineton Review and Akineton Label ).

5838258-4 | Anaemia, Neutropenia, Pancytopenia, Thrombocytopenia
Patient was taking Urbanyl (View Usage). Patient had the following side effects: anaemia, neutropenia, pancytopenia, thrombocytopenia on Jul 30, 2008 from Additional patient health information: Male patient , 70 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Urbanyl dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DEPAKENE (View Depakene Review and Depakene Label ), LOXEN (View Loxen Review and Loxen Label ), OFLOXACINE (View Ofloxacine Review and Ofloxacine Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), TRIATEC /00885601/ (View Triatec /00885601/ Review and Triatec /00885601/ Label ), INSULATARD /00646002/ (View Insulatard /00646002/ Review and Insulatard /00646002/ Label ), ZANIDIP (View Zanidip Review and Zanidip Label ). Patient was hospitalized.

5644283-9 | Haemoglobin Decreased
Adverse event was reported on Feb 21, 2008 by a Male patient taking Urbanyl (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), congenital aplastic anaemia, iron overload and. Location: FRANCE , 16 years of age, weighting 90.39 lb, After Urbanyl was administered, patient had the following side effects: haemoglobin decreased. During the same period patient was treated with PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), EXJADE (500 Mg Daily) (View Exjade Review and Exjade Label ).

5503643-7 | Hyperthyroidism
on Oct 24, 2007 Female patient from FRANCE , 59 years of age, was diagnosed with hypertension and was treated with Urbanyl (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthyroidism. Urbanyl dosage: . During the same period patient was treated with TEMESTA (View Temesta Review and Temesta Label ), TRASICOR (80 Mg, Bid) (View Trasicor Review and Trasicor Label ).


5448276-6 | Caesarean Section, Normal Newborn, Tubal Ligation
on Sep 03, 2007 Female patient from FRANCE , 36 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Urbanyl (View Usage). Patient had the following side effects: caesarean section, normal newborn, tubal ligation. Urbanyl dosage: 15 Mg/day. During the same period patient was treated with TEGRETOL (400 Mg/day) (View Tegretol Review and Tegretol Label ).

5448257-2 | Hypotonia Neonatal, Syndactyly
Patient was taking Urbanyl (View Usage). After Urbanyl was administered, patient had the following side effects: hypotonia neonatal, syndactyly on Sep 03, 2007 from FRANCE Additional patient health information: Male patient , weighting 8.05 lb, . Urbanyl dosage: Maternal Dose: 15 Mg/day. During the same period patient was treated with PAROXETINE HCL (Maternal Dose: 20 Mg/day) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TEGRETOL (Maternal Dose: 400 Mg/day) (View Tegretol Review and Tegretol Label ).

4677732-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Beta 2 Microglobulin Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cholestasis, Cytolytic Hepatitis
Adverse event was reported on Apr 25, 2005 by a Male patient taking Urbanyl (View Usage) (Dosage: 40 Mg Daily) was diagnosed with epilepsy (What is epilepsy?) and. Location: , 23 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, beta 2 microglobulin increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cholestasis, cytolytic hepatitis. During the same period patient was treated with POLARAMINE (6 Mg, Qd) (View Polaramine Review and Polaramine Label ), TRILEPTAL (1.8 G Daily) (View Trileptal Review and Trileptal Label ). Patient was hospitalized.

4669921-9 | Cholestasis, Cytolytic Hepatitis, Lymphadenopathy, Pyrexia, Rash Morbilliform, Splenomegaly
on Apr 25, 2005 Male patient from , 23 years of age, weighting 154.3 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Urbanyl (View Usage). Patient had the following side effects: cholestasis, cytolytic hepatitis, lymphadenopathy, pyrexia, rash morbilliform, splenomegaly. Urbanyl dosage: 40 Mg Daily. During the same period patient was treated with POLARAMINE (6 Mg, Qd) (View Polaramine Review and Polaramine Label ), TRILEPTAL (1.8 G Daily) (View Trileptal Review and Trileptal Label ). Patient was hospitalized.